Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Current Leases: 2019-2024

Historic Current Leases for Legend Biotech (LEGN) over the last 6 years, with Dec 2024 value amounting to $4.8 million.

  • Legend Biotech's Current Leases rose 69.83% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 69.83%. This contributed to the annual value of $4.8 million for FY2024, which is 50.99% up from last year.
  • Legend Biotech's Current Leases amounted to $4.8 million in FY2024, which was up 50.99% from $3.2 million recorded in FY2023.
  • Legend Biotech's Current Leases' 5-year high stood at $4.8 million during FY2024, with a 5-year trough of $911,000 in FY2021.
  • Moreover, its 3-year median value for Current Leases was $3.6 million (2022), whereas its average is $3.8 million.
  • Its Current Leases has fluctuated over the past 5 years, first tumbled by 37.77% in 2021, then skyrocketed by 291.11% in 2022.
  • Over the past 5 years, Legend Biotech's Current Leases (Yearly) stood at $1.5 million in 2020, then tumbled by 37.77% to $911,000 in 2021, then surged by 291.11% to $3.6 million in 2022, then dropped by 10.89% to $3.2 million in 2023, then surged by 50.99% to $4.8 million in 2024.